Related references
Note: Only part of the references are listed.Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer (vol 23, pg 186, 2013)
Da Yang et al.
CANCER CELL (2013)
miR-506 Regulates Epithelial Mesenchymal Transition in Breast Cancer Cell Lines
Himanshu Arora et al.
PLOS ONE (2013)
UPREGULATION OF MIR-506 LEADS TO DECREASED AE2 EXPRESSION IN BILIARY EPITHELIUM OF PATIENTS WITH PRIMARY BILIARY CIRRHOSIS
J. M. Banales et al.
JOURNAL OF HEPATOLOGY (2012)
A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth
K. L. Streicher et al.
ONCOGENE (2012)
Lung Cancer: New Biological Insights and Recent Therapeutic Advances
Suresh S. Ramalingam et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Cellular Redox Pathways as a Therapeutic Target in the Treatment of Cancer
Alberto J. Montero et al.
DRUGS (2011)
被撤回的出版物: Selective killing of cancer cells by a small molecule targeting the stress response to ROS (Retracted article. See vol. 561, pg. 420, 2018)
Lakshmi Raj et al.
NATURE (2011)
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
Bogdan Mateescu et al.
NATURE MEDICINE (2011)
MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells
Shipeng Feng et al.
NUCLEIC ACIDS RESEARCH (2011)
NF-κB addiction and its role in cancer: 'one size does not fit all'
M. M. Chaturvedi et al.
ONCOGENE (2011)
Requirement of the NF-κB Subunit p65/RelA for K-Ras-Induced Lung Tumorigenesis
Daniela S. Basseres et al.
CANCER RESEARCH (2010)
The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition
R. Vidya Priyadarsini et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Theaflavins retard human breast cancer cell migration by inhibiting NF-κB via p53-ROS cross-talk
Arghya Adhikary et al.
FEBS LETTERS (2010)
MicroRNA control of signal transduction
Masafumi Inui et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis
Munekazu Yamakuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Synergistic Growth Inhibition of Squamous Cell Carcinoma of the Head and Neck by Erlotinib and Epigallocatechin-3-Gallate: The Role of p53-Dependent Inhibition of Nuclear Factor-κB
A. R. M. Ruhul Amin et al.
CANCER PREVENTION RESEARCH (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
p53 Attenuates Lipopolysaccharide-Induced NF-κB Activation and Acute Lung Injury
Gang Liu et al.
JOURNAL OF IMMUNOLOGY (2009)
MicroRNA-21 protects against the H2O2-induced injury on cardiac myocytes via its target gene PDCD4
Yunhui Cheng et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
NF-κB: A Key Player in Lung Cancer
[Anonymous]
CELL (2009)
Modulation of microRNA processing by p53
Hiroshi I. Suzuki et al.
NATURE (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers
H. Ebi et al.
ONCOGENE (2009)
Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma
Etienne Meylan et al.
NATURE (2009)
Updates on p53: modulation of p53 degradation as a therapeutic approach
A. Dey et al.
BRITISH JOURNAL OF CANCER (2008)
p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle Arrest
Christian J. Braun et al.
CANCER RESEARCH (2008)
Nuclear factor-kB activation: From bench to bedside
Gautam Sethi et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
The genetics of the p53 pathway, apoptosis and cancer therapy
Alexei Vazquez et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells
Hiroshi Tazawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Nutlin-3 inhibits the NFκB pathway in a p53-dependent manner implications in lung cancer therapy
Anwesha Dey et al.
CELL CYCLE (2007)
p53-mediated activation of miRNA34 candidate tumor-suppressor genes
Guido T. Bommer et al.
CURRENT BIOLOGY (2007)
A microRNA component of the p53 tumour suppressor network
Lin He et al.
NATURE (2007)
Rapid evolution of an X-linked microRNA cluster in primates
Rui Zhang et al.
GENOME RESEARCH (2007)
A critical role for p53 in the control of NF-κB-dependent gene expression in TLR4-stimulated dendritic cells exposed to genistein
Nathalie Dijsselbloem et al.
JOURNAL OF IMMUNOLOGY (2007)
Integrating cell-signalling pathways with NF-kappa B and IKK function
Neil D. Perkins
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Nuclear factor-κB (NF-κB) is frequently expressed in lung cancer and preneoplastic lesions
Ximing Tang et al.
CANCER (2006)
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
D. S. Basseres et al.
ONCOGENE (2006)
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate
Dunyaporn Trachootham et al.
CANCER CELL (2006)
Nuclear factor-κB in cancer development and progression
Michael Karin
NATURE (2006)
The complexity of p53 stabilization and activation
M. F. Lavin et al.
CELL DEATH AND DIFFERENTIATION (2006)
Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-κB-dependent mechanism of p53 suppression in tumors
KV Gurova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
NFκB:: Linking inflammation and immunity to cancer development and progression
M Karin et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-κB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-jun n-terminal kinase 1 activation
Y Dai et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The p53 pathway: positive and negative feedback loops
SL Harris et al.
ONCOGENE (2005)
ROS stress in cancer cells and therapeutic implications
H Pelicano et al.
DRUG RESISTANCE UPDATES (2004)
Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity
EO Hileman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Proliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cells
YL Hsu et al.
LIFE SCIENCES (2004)
Role of reactive oxygen species in apoptosis:: implications for cancer therapy
JM Matés et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2000)